Tylenol Maker Kenvue Met With RFK Jr. In A Bid To Keep OTC Painkiller Off Autism List: Report

Published : Sep 12, 2025, 09:20 PM IST
https://stocktwits.com/news-articles/markets/equity/tylenol-kenvue-met-rfk-jr-to-keep-off-autism-list/chw8MshRdDV

Synopsis

According to a Bloomberg report, Kenvue confirmed the meeting with RFK Jr., maintaining that acetaminophen, the active ingredient in Tylenol, does not cause autism.

Tylenol maker Kenvue Inc. (KVUE) reportedly met with the U.S. Health Secretary Robert F. Kennedy Jr. in a bid to keep the over-the-counter painkiller off a list of treatments causing autism.

According to a Bloomberg report, Kenvue confirmed the meeting with RFK Jr., maintaining that acetaminophen, the active ingredient in Tylenol, does not cause autism.

Get updates to this story developing <directly on Stocktwits<.<

For updates and corrections, email newsroom[at]stocktwits[dot]com.<

PREV
Read more

Recommended Stories

NIO Stock Could Get Geely Boost As Chip Push Expands Beyond Own EVs — Analyst Calls Shares ‘Undervalued’
Broadcom Sees $230B In AI Revenue By 2028, Driven By 'Geniuses' OpenAI, Anthropic: Analyst Says Some Risks Remain Unresolved